http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2015746-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9aa0e2b2cb1965adc4fbd68b805351f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba80d0acb49bf7839b848b56bbdfd40 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e27a79d573d86c084e3c8d058fe0a81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf8a535f6057b560c113b114378a34ab |
| publicationDate | 2009-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2015746-A2 |
| titleOfInvention | Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| abstract | The invention relates to a compound of formula (I) or pharmaceutically acceptable salts thereof which can be used for producing a pharmaceutical preparation for preventing or treating cancerous diseases, pathological consequences of alcohol abuse, viral hepatitis, steatohepatitis, acute and chronic pancreatitis, toxic renal diseases, hepatic insulin resistance in diabetes mellitus, hepatic damage in Wilson's disease and/or sideroses and/or ischaemic reperfusion damage as an antidote against environmental toxins and medicament intoxication in order to extend the resistance time of medicaments in organisms, and/or for combating toxic side effects of the administration of chemotherapeutics. B<SUB>6</SUB>, B<SUB>7</SUB> and B<SUB>8</SUB> are identical or different and represent 0, S, NH, PO<SUB>4</SUB>, Se, SO<SUB>4</SUB>. R<SUB>1</SUB> is identical to H or a C<SUB>6</SUB>- and/or C<SUB>7</SUB>-to C<SUB>26</SUB>- and/or C<SUB>20</SUB>-alkyl chain, and R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB> and R<SUB>5</SUB> can be identical or different and represents an H or C<SUB>1</SUB>- to C<SUB>3</SUB>- alkyl, alkanol, alkylamine and/or alkylthiol-group. R<SUB>6</SUB>, R<SUB>7</SUB> and R<SUB>8</SUB> can be identical or different and H represents a substituted or unsubstituted C<SUB>6</SUB>- and/or C<SUB>7</SUB>- to C<SUB>26</SUB>-alkyl radical, a glucose radical, a positive or negatively charged amino acid radical and a - (CH<SUB>2</SUB>)<SUB>n</SUB>-N<SUP>+</SUP>(R<SUB>9</SUB>, R<SUB>10</SUB>, R<SUB>11</SUB>). R<SUB>9</SUB>, R<SUB>10</SUB>, R<SUB>11 </SUB>is H, methyl-, ethyl- and/or propyl radical, and at least two of R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB> and R<SUB>5 </SUB> can together form a polyol radical and n is a whole number from 1 to 5. |
| priorityDate | 2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 346.